CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Businesses  /  Generics  /  Formulation R&D

RESEARCH & DEVELOPMENT

Formulation R&D

Our formulation R&D team has expertise in development of products across various dosage forms viz.
ORAL SOLIDS
(tablets, capsules, modified release,
sublingual and buccal formulations)
LIQUIDS
AND SEMI-SOLIDS
PARENTERALS
(lyophilized and liquid vials,
cartridges, PFS)
SOLUTIONS, SUSPENSIONS
AND EMULSIONS
Formulation R&D facility has been established to develop multiple products across these dosage forms

Development facility is equipped with latest technology including but not limited to hot-melt extrusion, nano-sizing, high pressure homogenization, direct compression, high shear wet granulation, fluid bed processing (granulation, drying, coating), dry granulation (roller compaction, slugging), extrusion spheronization, perforated pan tablet coating using auto-coaters, capsule filling (powder, granules, pellets) and spray drying

Analytical R&D facility includes a wide range of equipment to support various techniques including but not limited to chromatographic separation (HPLC, UPLC, GC), detection (UV, fluorescence, Ultra-CAD, RI, FID, TCD), characterisation for polymorphic forms (Powder X-ray diffraction), physicochemical characterisation using thermal (DSC, TGA), particle size determination (Malvern PSD, Zeta sizer), dynamic vapour sorption studies (DVS), dissolution development & testing (USP-I, II & III), elemental determinations (ICP-OES), spectroscopic analysis (FTIR, NIR, Raman, & UV) and moisture determination (Karl fisher technique).

Siddharth Mittal
KEY MANAGEMENT TEAM
PRODUCTS
PRESS RELEASES
CORPORATE GOVERNANCE
R&D
WORKING WITH US
Share
Previous Next
Close
Test Caption
Test Description goes like this